Ilpo Huhtaniemi

ORCID: 0000-0001-9092-7886 · 11 papers in corpus
lab-animal 2025
Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-025-01292-5

BACKGROUND: Extragonadal follicle-stimulating hormone (FSH) receptor (FSHR) expression in various cancers and their endothelial vessel cells has highlighted novel opportunities for targeted FSHR therapy. METHODS: We investigated the specifi…

other 2023
Genes ·doi:10.3390/genes14061269

BACKGROUND: Specific polymorphisms might influence controlled ovarian stimulation in women undergoing assisted reproductive technologies (ARTs). Data regarding possible interactions of these polymorphisms are still scanty. The aim of this a…

other 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.991106
observational 2021
Andrology ·doi:10.1111/andr.13063

BACKGROUND: Infertility affects 15%-25% of all couples during their reproductive life span. It is a significant societal and public health problem with potential psychological, social, and economic consequences. Furthermore, infertility has…

review 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00032

Expression of the follicle-stimulating hormone receptor (FSHR), besides gonadal tissues, has recently been detected in several extragonadal normal and tumorous tissues, including different types of primary and metastatic cancer and tumor ve…

review 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00398

The purpose of a pharmacogenomic approach is to tailor treatment on the basis of an individual human genotype. This strategy is becoming increasingly common in medicine, and important results have been obtained in oncologic and antimicrobia…

other 2016
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2016-1014

CONTEXT: FSH receptor (FSHR), besides being expressed in gonads, is also expressed in some extragonadal tissues at low levels. OBJECTIVE: We examined the functional expression of FSHR in different types of endometriotic lesions. DESIGN: E…

lab-animal 2004
The American Journal of Pathology ·doi:10.1016/s0002-9440(10)63191-4

The present study was undertaken to analyze the effect of a P450 aromatase inhibitor (finrozole) on 4-month-old transgenic mice expressing human P450 aromatase (P450arom) under the human ubiquitin C promoter (AROM+). AROM+ mice present seve…

observational 2002
Human Reproduction ·doi:10.1093/humrep/17.6.1532

BACKGROUND: Subfertile women with endometriosis have been reported to demonstrate impaired follicular growth, ovulatory dysfunction and disturbed LH patterns. In addition, abnormal LH and/or LH receptors have been linked with endometriosis-…

observational 1993
·doi:10.1097/00006254-199301000-00021

Department of Physiology, University of Turku, and Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland

other 1991
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a137516

Thirty-five women who had been operated on for mild or moderate endometriosis were evaluated through 40 menstrual cycles by daily measurements of salivary progesterone concentrations. As controls, 17 women with normal ovulatory cycles and n…